Folic Acid Supplement Prevents Phenytoin-Induced Gingival Hyperplasia
Researchers at the Division of Pediatric Neurology, Neurosciences Centre, New Delhi, India, performed a randomized, double-blind, placebo-controlled 6-month trial of oral folic acid supplement (0.5 mg/day) in children aged 6-15 years treated with phenytoin for epilepsy.
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Pediatric Neurology Briefs Publishers
2011-05-01
|
| Seria: | Pediatric Neurology Briefs |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.pediatricneurologybriefs.com/articles/632 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|